Related Experiment Video
Updated: May 10, 2025

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
Genetics of remnant cholesterol
Anders B Wulff1,2, Børge G Nordestgaard1,2,3
1Department of Clinical Biochemistry.
Purpose Of Review:
Remnant cholesterol is receiving increasing attention as a target to reduce residual atherosclerotic cardiovascular disease (ASCVD) risk in individuals already treated with statins. New therapeutic options as antisense oligonucleotides, small interfering RNA, and monoclonal antibodies allow specific targeting of genes and proteins to counter pathological pathways promoted by these genes. Identifying genetic determinants of remnant cholesterol and relating these to risk of ASCVD is thus an appealing path to identifying and evaluating new and existing drug targets.
Recent Findings:
Human genetic epidemiology has identified several genetic variants in genes involved in lipoprotein metabolism with effect on plasma concentrations of remnant cholesterol. Lipoprotein lipase (LPL) is central to the metabolism of remnant lipoproteins and plasma concentrations of remnant cholesterol, and several genes, including APOC3 , ANGPTL3 and ANGPTL4 , whose gene products regulate activity of LPL, are important determinants of remnant cholesterol.
Summary:
Current opinion is that remnant cholesterol is a likely causal factor in the development of ASCVD. Human genetic studies have identified several genes, many involved in LPL function, affecting remnant cholesterol concentrations, some of which are already used as therapeutic targets, and others which are subject to investigation of their remnant cholesterol and triglyceride-lowering effect in clinical trials.
Insights
Remnant cholesterol, a risk factor for atherosclerotic cardiovascular disease (ASCVD), is influenced by genetic factors. Understanding these genetic determinants, particularly those affecting lipoprotein lipase (LPL), can reveal new therapeutic targets.
Area of Science:
- Cardiovascular Genetics
- Lipid Metabolism
- Pharmacogenomics
Background:
- Remnant cholesterol is an emerging target for reducing residual atherosclerotic cardiovascular disease (ASCVD) risk in statin-treated patients.
- Novel therapies like antisense oligonucleotides and monoclonal antibodies enable targeted intervention in pathological pathways.
- Identifying genetic links to remnant cholesterol can guide the evaluation of drug targets.
Purpose of the Study:
- To explore genetic determinants of remnant cholesterol.
- To investigate the relationship between these genetic factors and ASCVD risk.
- To identify and evaluate potential drug targets for managing remnant cholesterol.
Main Methods:
- Human genetic epidemiology studies.
- Analysis of genetic variants influencing lipoprotein metabolism.
- Investigation of genes affecting lipoprotein lipase (LPL) activity.
Main Results:
- Several genetic variants impacting remnant cholesterol levels have been identified.
- Genes such as APOC3, ANGPTL3, and ANGPTL4, which regulate LPL activity, are key determinants.
- Lipoprotein lipase (LPL) plays a central role in remnant lipoprotein metabolism.
Conclusions:
- Remnant cholesterol is considered a likely causal factor in ASCVD development.
- Genetic studies have pinpointed several genes, many related to LPL function, that influence remnant cholesterol.
- Some identified genes are already therapeutic targets, while others are under investigation for their lipid-lowering effects.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Inheritance of Chromatin Structures
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Lipid Absorption
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
X and Y Chromosomes
The germline cells such as egg and sperm cells carry only half the number of chromosomes, i.e., 22 autosomes and one sex chromosome. All eggs have an X chromosome, while sperm cells can carry an X or...

